Table 3.
Outcome or subgroup title | References | Trials, n | Participants, n | SMDa (IVb, random, 95% CI) | Overall effect, P value | Heterogeneity I2 value, % | |||||||||||||
|
|
|
IGc | CGd |
|
|
|
||||||||||||
1. HbA1ce | [26,27,57,59] | 4 | 148 | 154 | −0.98 (−2.199 to 0.239) | .12 | 95.5 | ||||||||||||
|
1.1 Subgroup analysis regarding intervention technology |
|
4 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
1.1.1 Mobile app | [26] | 1 | 64 | 60 | −2.368 (−2.829 to −1.908) | <.001 | N/Af | ||||||||||
|
|
1.1.2 Website | [27,57,59] | 3 | 84 | 94 | −0.49 (−1.341 to 0.36) | .26 | 86.3 | ||||||||||
|
1.2 Subgroup analysis regarding intervention interactivity |
|
4 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
1.2.1 Interactive interventions | [26,57,59] | 3 | 126 | 132 | −0.813 (−2.375 to 0.749) | .31 | 96.9 | ||||||||||
|
|
1.2.2 Noninteractive interventions | [27] | 1 | 22 | 22 | −1.50 (−2.172 to −0.828) | <.001 | N/A | ||||||||||
|
1.3 Subgroup analysis regarding intervention format |
|
4 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
1.3.1 Personalized format | [26,27,59] | 3 | 118 | 107 | −1.312 (−2.756 to 0.131) | .08 | 95.2 | ||||||||||
|
|
1.3.2 Nonpersonalized format | [57] | 1 | 30 | 47 | 0.00 (−0.458 to 0.458) | .99 | N/A | ||||||||||
|
1.4 Sensitivity analysis | [26,59] | 2 | 96 | 85 | −1.219 (−3.478 to 1.039) | .29 | 97.6 | |||||||||||
2. FBGg | [16,19,26-28,44,56,58,59] | 9 | 410 | 380 | −1.764 (−2.972 to −0.557) | .004 | 97.9 | ||||||||||||
|
2.1 Subgroup analysis regarding intervention technology |
|
8 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
2.1.1 Mobile app | [16,26,28,44,56] | 5 | 302 | 277 | −3.094 (−5.326 to −0.861) | .007 | 98.9 | ||||||||||
|
|
2.1.2 Website | [27,58,59] | 3 | 96 | 91 | −0.099 (−0.395 to 0.198) | .52 | 5.2 | ||||||||||
|
2.2 Subgroup analysis regarding intervention interactivity |
|
9 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
2.2.1 Interactive interventions | [19,26,44,56,58,59] | 6 | 233 | 223 | −2.51 (−4.716 to −0.303) | .03 | 98.6 | ||||||||||
|
|
2.2.2 Noninteractive interventions | [16,27,28] | 3 | 177 | 157 | −0.389 (−1.05 to 0.271) | .25 | 87 | ||||||||||
|
2.3 Subgroup analysis regarding intervention format |
|
9 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
2.3.1 Personalized format | [26-28,44,56-58] | 7 | 300 | 283 | −2.24 (−3.889 to −0.591) | .008 | 98.3 | ||||||||||
|
|
2.3.2 Nonpersonalized format | [16,19] | 2 | 110 | 97 | −0.026 (−0.304 to 0.251) | .85 | .8 | ||||||||||
|
2.4 Sensitivity analysis | [16,19,26,44,56,58,59] | 7 | 331 | 308 | −2.124 (−3.771 to −0.478) | .01 | 98.4 | |||||||||||
3. 1hBGh | [27,28,44,56] | 4 | 162 | 154 | −2.077 (−4.568 to 0.415) | .10 | 98.5 | ||||||||||||
|
3.1 Subgroup analysis regarding intervention technology |
|
4 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
3.1.1 Mobile app | [28,44,56] | 3 | 140 | 132 | −2.993 (−6.523 to 0.538) | .10 | 98.9 | ||||||||||
|
|
3.1.2 Website | [27] | 1 | 22 | 22 | 0.58 (−0.023 to 1.184) | .06 | N/A | ||||||||||
|
3.2 Subgroup analysis regarding intervention interactivity |
|
4 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
3.2.1 Interactive interventions | [44,56] | 2 | 83 | 82 | −4.529 (−11.792 to 2.733) | .22 | 99.2 | ||||||||||
|
|
3.2.2 Noninteractive interventions | [27,28] | 2 | 79 | 72 | 0.23 (−0.358 to 0.817) | .44 | 64 | ||||||||||
|
3.3 Sensitivity analysis | [44,56] | 2 | 83 | 82 | −4.529 (−11.792 to 2.733) | .22 | 99.2 | |||||||||||
4. 2hBGi | [16,19,26,28,44,58,59] | 7 | 328 | 298 | −1.433 (−2.561 to −0.304) | .01 | 97.3 | ||||||||||||
|
4.1 Subgroup analysis regarding intervention technology |
|
6 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
4.1.1 Mobile app | [16,26,28,44] | 4 | 242 | 217 | −2.527 (−4.56 to −0.495) | .02 | 98.6 | ||||||||||
|
|
4.1.2 Website | [58,59] | 2 | 74 | 69 | −0.017 (−0.346 to 0.312) | .92 | 0 | ||||||||||
|
4.2 Subgroup analysis regarding intervention interactivity |
|
7 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
4.2.1 Interactive interventions | [19,26,44,58,59] | 5 | 173 | 163 | −1.979 (−3.987 to 0.029) | .05 | 98.1 | ||||||||||
|
|
4.2.2 Noninteractive interventions | [16,28] | 2 | 155 | 135 | −0.318 (−0.985 to 0.349) | .35 | 86.7 | ||||||||||
|
4.3 Subgroup analysis regarding intervention format |
|
7 |
|
|
|
Subtotals only |
|
|||||||||||
|
|
4.3.1 Personalized format | [26,28,44,58,59] | 5 | 218 | 201 | −2.009 (−3.722 to −0.296) | .02 | 98.1 | ||||||||||
|
|
4.3.2 Nonpersonalized format | [16,19] | 2 | 110 | 97 | −0.032 (−0.305 to 0.242) | .82 | 0 | ||||||||||
|
4.4 Sensitivity analysis | [16,19,26,44,58,59] | 6 | 271 | 248 | −1.598 (−3.012 to −0.185) | .03 | 97.7 |
aSMD: standardized mean difference.
bIV: inverse variance.
cIG: intervention group.
dCG: control group.
eHbA1c: glycated hemoglobin.
fN/A: not applicable.
gFBG: fasting blood glucose.
h1hBG: 1-hour postprandial blood glucose.
i2hBG: 2-hour postprandial blood glucose.